De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
HCA Overzicht aandelen
HCA Healthcare, Inc. is via haar dochterondernemingen eigenaar en exploitant van ziekenhuizen en aanverwante zorginstellingen in de Verenigde Staten.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 5/6 |
| Toekomstige groei | 2/6 |
| Prestaties in het verleden | 2/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 0/6 |
Beloningen
Risicoanalyse
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Navigating Growth And Risks, A Healthcare Company's Financial Journey To Expansion And Efficiency
HCA Healthcare, Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$406.48 |
| 52 Week Hoogtepunt | US$416.72 |
| 52 Week Laag | US$215.96 |
| Bèta | 1.68 |
| 11 maand verandering | 2.26% |
| 3 maanden verandering | 26.17% |
| 1 Jaar Verandering | 66.56% |
| 33 jaar verandering | 56.34% |
| 5 jaar verandering | 225.18% |
| Verandering sinds IPO | 1,210.38% |
Recent nieuws en updates
HCA Healthcare, Inc. (NYSE:HCA) Not Lagging Market On Growth Or Pricing
Oct 16
HCA Healthcare, Inc.'s (NYSE:HCA) Intrinsic Value Is Potentially 63% Above Its Share Price
Oct 01HCA Healthcare: Still A Great Play On Long-Term Growth And Valuation
Sep 28Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?
Sep 16Recent updates
HCA Healthcare, Inc. (NYSE:HCA) Not Lagging Market On Growth Or Pricing
Oct 16HCA Healthcare, Inc.'s (NYSE:HCA) Intrinsic Value Is Potentially 63% Above Its Share Price
Oct 01HCA Healthcare: Still A Great Play On Long-Term Growth And Valuation
Sep 28Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?
Sep 16Does HCA Healthcare (NYSE:HCA) Have A Healthy Balance Sheet?
Sep 01Results: HCA Healthcare, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Jul 26Are Investors Undervaluing HCA Healthcare, Inc. (NYSE:HCA) By 27%?
Jun 21HCA Healthcare, Inc.'s (NYSE:HCA) P/E Still Appears To Be Reasonable
Jun 06Is It Too Late To Consider Buying HCA Healthcare, Inc. (NYSE:HCA)?
May 21HCA Healthcare, Inc. Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next
Apr 30Capital Investment Trends At HCA Healthcare (NYSE:HCA) Look Strong
Apr 11HCA Healthcare Is Finally At Fair Value (Rating Downgrade)
Mar 19HCA Healthcare: Improving Margins Now Reflected In Shares (Rating Downgrade)
Feb 29HCA Healthcare (NYSE:HCA) Is Increasing Its Dividend To $0.66
Feb 25HCA Healthcare (NYSE:HCA) Is Paying Out A Larger Dividend Than Last Year
Feb 05HCA Healthcare, Inc. (NYSE:HCA) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 02HCA Healthcare, Inc. (NYSE:HCA) Shares Could Be 40% Below Their Intrinsic Value Estimate
Jan 21At US$276, Is HCA Healthcare, Inc. (NYSE:HCA) Worth Looking At Closely?
Jan 08HCA Healthcare, Inc.'s (NYSE:HCA) Share Price Is Matching Sentiment Around Its Earnings
Dec 25HCA Healthcare Continues To Impress
Dec 14Should You Be Adding HCA Healthcare (NYSE:HCA) To Your Watchlist Today?
Dec 11HCA Remains Attractive Despite A JV Misstep
Nov 20These 4 Measures Indicate That HCA Healthcare (NYSE:HCA) Is Using Debt Extensively
Oct 26HCA Healthcare: Rx For Success
Oct 10A Look Into HCA Healthcare's (NYSE:HCA) Impressive Returns On Capital
Oct 09HCA Healthcare: Impact Of Medicare Advantage Growth And Demographic Shift
Sep 30At US$256, Is It Time To Put HCA Healthcare, Inc. (NYSE:HCA) On Your Watch List?
Sep 17HCA Healthcare Is Beating The Industry
Sep 13Here's Why HCA Healthcare (NYSE:HCA) Can Manage Its Debt Responsibly
Jul 25HCA Healthcare (NYSE:HCA) Is Aiming To Keep Up Its Impressive Returns
Jul 10HCA Healthcare's Service Optimization And Capabilities Support Long-Run Growth
Jul 03HCA Healthcare, Inc.'s (NYSE:HCA) Intrinsic Value Is Potentially 45% Above Its Share Price
Jun 25Is Now The Time To Look At Buying HCA Healthcare, Inc. (NYSE:HCA)?
Jun 09HCA Healthcare's (NYSE:HCA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 09HCA Healthcare (NYSE:HCA) Has Announced That It Will Be Increasing Its Dividend To $0.60
May 25HCA Healthcare (NYSE:HCA) Has A Pretty Healthy Balance Sheet
Apr 22HCA Healthcare (NYSE:HCA) Knows How To Allocate Capital
Apr 04Are Investors Undervaluing HCA Healthcare, Inc. (NYSE:HCA) By 45%?
Mar 16At US$249, Is HCA Healthcare, Inc. (NYSE:HCA) Worth Looking At Closely?
Feb 26HCA Healthcare's (NYSE:HCA) Shareholders Will Receive A Bigger Dividend Than Last Year
Jan 30Rendement voor aandeelhouders
| HCA | US Healthcare | US Markt | |
|---|---|---|---|
| 7D | 5.0% | -3.2% | 1.1% |
| 1Y | 66.6% | 4.0% | 36.0% |
Rendement versus industrie: HCA overtrof de US Healthcare industrie, die het afgelopen jaar een rendement 10.8 % opleverde.
Rendement versus markt: HCA overtrof de US markt, die het afgelopen jaar een rendement opleverde van 34.1 %.
Prijsvolatiliteit
| HCA volatility | |
|---|---|
| HCA Average Weekly Movement | 2.8% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 14.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: HCA heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van HCA is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1968 | 265,000 | Sam Hazen | www.hcahealthcare.com |
HCA Healthcare, Inc. is via haar dochterondernemingen eigenaar en exploitant van ziekenhuizen en aanverwante gezondheidszorginstellingen in de Verenigde Staten. Het exploiteert algemene en acute zorgziekenhuizen die medische en chirurgische diensten bieden, waaronder klinische zorg, intensive care, hartzorg, diagnostische en spoedeisende hulp; en poliklinische diensten, zoals poliklinische chirurgie, laboratorium, radiologie, ademhalingstherapie, cardiologie en fysiotherapie. Het bedrijf exploiteert ook poliklinische gezondheidszorgfaciliteiten bestaande uit vrijstaande ambulante chirurgische centra, vrijstaande faciliteiten voor spoedeisende hulp, faciliteiten voor spoedeisende hulp, inloopklinieken, diagnostische en beeldvormingscentra, revalidatie- en fysiotherapiecentra, bestralings- en oncologische therapiecentra, artsenpraktijken en diverse andere faciliteiten.
HCA Healthcare, Inc. Samenvatting
| HCA fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$105.61b |
| Inkomsten(TTM) | US$5.74b |
| Inkomsten(TTM) | US$68.35b |
18.3x
Koers/Winstverhouding1.5x
P/S-verhoudingIs HCA overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| HCA resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$68.35b |
| Kosten van inkomsten | US$40.82b |
| Brutowinst | US$27.52b |
| Overige uitgaven | US$21.79b |
| Inkomsten | US$5.74b |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
Oct 25, 2024
| Winst per aandeel (EPS) | 22.23 |
| Brutomarge | 40.27% |
| Nettowinstmarge | 8.40% |
| Schuld/Eigen Vermogen Verhouding | 3,053.0% |
Hoe presteerde HCA op de lange termijn?
Bekijk historische prestaties en vergelijking